Form 4: CapsoVision Director Awarded 2,887 RSUs

CapsoVision Director Hui Ying Kuo was granted 2,887 Restricted Stock Units, aligning her interests with shareholders, with vesting scheduled for December 31, 2025.

Summary

• Hui Ying Kuo, a Director of CapsoVision, Inc., acquired 2,887 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of CapsoVision's common stock.
• The RSUs are scheduled to vest on December 31, 2025.
• Following this transaction, Hui Ying Kuo beneficially owns 2,887 derivative securities (RSUs).
• The transaction date for the RSU acquisition was September 15, 2025.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive development as it aligns the director's financial interests with the long-term performance of the company and its shareholders. It represents standard practice for executive and director compensation.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, incentivizing long-term performance.
• Equity compensation is a standard practice for attracting and retaining qualified board members.

Risks

• The value of the RSUs is contingent on the future performance of CapsoVision's common stock.
• The RSUs are subject to vesting conditions, meaning the director will only receive the shares if they remain with the company until December 31, 2025.

Future Outlook

The 2,887 Restricted Stock Units are scheduled to vest on December 31, 2025, at which point they will convert into shares of CapsoVision's common stock, subject to the director meeting the vesting conditions.

Industry Context

The grant of Restricted Stock Units to a director is a common form of equity compensation in the U.S. corporate landscape, particularly for publicly traded companies. It serves to align the interests of board members with those of shareholders by tying a portion of their compensation to the company's stock performance and long-term value creation. This practice is prevalent across various industries as a governance best practice.

Comparison to Industry Standards

• Equity grants to directors, such as RSUs, are a standard component of compensation packages in publicly traded companies across industries, including technology and medical devices (CapsoVision's likely sector).
• The specific number of RSUs (2,887) would typically be evaluated against peer company compensation for non-executive directors, considering company size, market capitalization, and industry benchmarks. Without specific peer data, a direct comparison is not possible from this filing alone.
• The vesting schedule (single cliff vest on December 31, 2025) is a common structure for director equity awards, often tied to continued service.

Related Party Transactions

• The acquisition of Restricted Stock Units by a director is an insider transaction, which is a form of related party dealing, as the director is considered a related party to the issuer.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially leading to more shareholder-friendly decisions.

Next Steps

• The Restricted Stock Units are scheduled to vest on December 31, 2025, at which point they will convert into common stock.

Key Dates

Keywords

CapsoVision, CV, Hui Ying Kuo, Restricted Stock Units, RSU, Director, Equity Compensation, Insider Transaction, SEC Form 4, Vesting, Common Stock